MPFS Final Rule Decreases Conversion Factor for 2027
CMS finalized the 2027 Medicare Physician Fee Schedule, including conversion factor reductions and QPP policy updates.
Read moreMain Content
NIH Launches NIH RADx Tech ACT ENDO Challenge
Aug. 13, 2024
The National Institutes of Health (NIH) recently announced the NIH RADx® Tech ACT ENDO Challenge, a new initiative intended to accelerate the development of innovative technologies, such as imaging technologies, for diagnosing endometriosis.
The challenge offers up to $3 million to shorten the time to diagnose, eliminate the invasiveness of current techniques, and/or improve accessibility, safety, convenience and costs of diagnosis. This initiative is co-led by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
The ACT ENDO Challenge seeks innovative and non-invasive solutions, in addition to imaging technologies, including in vitro diagnostic devices, clinical laboratory tests, wearable devices, smartphone-enabled diagnostic tools, integrated sensing technologies and digital health platforms.
This two-year challenge will consist of three phases. Submissions to Phase I are due Oct. 11, and final winners are expected to be announced in March 2026. Teams may include start-ups, small- or mid-size businesses, non-profit organizations and academic institutions. Find more information online, including details about eligibility, rules and how to register.
For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.
The challenge offers up to $3 million to shorten the time to diagnose, eliminate the invasiveness of current techniques, and/or improve accessibility, safety, convenience and costs of diagnosis. This initiative is co-led by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
The ACT ENDO Challenge seeks innovative and non-invasive solutions, in addition to imaging technologies, including in vitro diagnostic devices, clinical laboratory tests, wearable devices, smartphone-enabled diagnostic tools, integrated sensing technologies and digital health platforms.
This two-year challenge will consist of three phases. Submissions to Phase I are due Oct. 11, and final winners are expected to be announced in March 2026. Teams may include start-ups, small- or mid-size businesses, non-profit organizations and academic institutions. Find more information online, including details about eligibility, rules and how to register.
For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.
